ARCHIVES

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

Irinotecan And Carboplatin Improve Response In NSCLC

June 24, 2005

Meta-Analysis Of Randomized Trials Shows Aspirin Reduces Colon Polyp Recurrence

February 27, 2009

NCAB Rejects Automatic Loss Of Comprehensive Status For Center Without Core Grants

September 29, 1978

John Niederhuber named NCI chief operating officer; the surgeon was asked to leave two previous positions.

October 7, 2005

NIH Policy On Diversity In Sponsored Meetings

June 16, 1995

CCIRC Members Now Feel At Home In DCT

March 3, 1978